Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Gottlin

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer|October 6, 2007
Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancerLuke F M Hoagland, Michael J Campa, Elizabeth B Gottlin, et al.
Molecular Cancer Therapeutics|March 30, 2023
Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103Ryan T Bushey, Ruchi Saxena, Michael J Campa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Panel of serum biomarkers for the diagnosis of lung cancerEdward F Patz, Michael J Campa, Elizabeth B Gottlin, et al.
Cancer Immunology, Immunotherapy : CII|January 8, 2016
Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discoveryMichael J Campa, M Anthony Moody, Ruijun Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|January 24, 2022
Prognostic significance of a complement factor H autoantibody in early stage NSCLCElizabeth B Gottlin, Michael J Campa, Rikesh Gandhi, et al.
Frontiers in Cell and Developmental Biology|February 23, 2024
Complement factor H: a novel innate immune checkpoint in cancer immunotherapyRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancerElizabeth B Gottlin, Rex C Bentley, Michael J Campa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating AntibodyRuchi Saxena, Ryan T Bushey, Michael J Campa, et al.
Journal of Biomolecular Screening|July 15, 2003
High-throughput screen for inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase by surrogate ligand competitionElizabeth B Gottlin, R Edward Benson, Scott Conary, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Biomarkers to help guide management of patients with pulmonary nodulesEdward F Patz, Michael J Campa, Elizabeth B Gottlin, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer|October 6, 2007
Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancerLuke F M Hoagland, Michael J Campa, Elizabeth B Gottlin, et al.
Molecular Cancer Therapeutics|March 30, 2023
Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103Ryan T Bushey, Ruchi Saxena, Michael J Campa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Panel of serum biomarkers for the diagnosis of lung cancerEdward F Patz, Michael J Campa, Elizabeth B Gottlin, et al.
Cancer Immunology, Immunotherapy : CII|January 8, 2016
Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discoveryMichael J Campa, M Anthony Moody, Ruijun Zhang, et al.
Cancer Biomarkers : Section a of Disease Markers|January 24, 2022
Prognostic significance of a complement factor H autoantibody in early stage NSCLCElizabeth B Gottlin, Michael J Campa, Rikesh Gandhi, et al.
Frontiers in Cell and Developmental Biology|February 23, 2024
Complement factor H: a novel innate immune checkpoint in cancer immunotherapyRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
The Association of Intratumoral Germinal Centers with early-stage non-small cell lung cancerElizabeth B Gottlin, Rex C Bentley, Michael J Campa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating AntibodyRuchi Saxena, Ryan T Bushey, Michael J Campa, et al.
Journal of Biomolecular Screening|July 15, 2003
High-throughput screen for inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase by surrogate ligand competitionElizabeth B Gottlin, R Edward Benson, Scott Conary, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Biomarkers to help guide management of patients with pulmonary nodulesEdward F Patz, Michael J Campa, Elizabeth B Gottlin, et al.
Pageof 3